Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 402

1.

Exacerbations in patients with chronic obstructive pulmonary disease receiving physical therapy: a cohort-nested randomised controlled trial.

Beekman E, Mesters I, Hendriks EJ, Muris JW, Wesseling G, Evers SM, Asijee GM, Fastenau A, Hoffenkamp HN, Gosselink R, van Schayck OC, de Bie RA.

BMC Pulm Med. 2014 Apr 26;14:71. doi: 10.1186/1471-2466-14-71.

2.

Efficacy of a physical exercise training programme COPD in primary care: study protocol of a randomized controlled trial.

Fastenau A, Muris JW, de Bie RA, Hendriks EJ, Asijee GM, Beekman E, Gosselink R, van Schayck OC.

BMC Public Health. 2014 Aug 3;14:788. doi: 10.1186/1471-2458-14-788.

3.

Effectiveness of the Assessment of Burden of Chronic Obstructive Pulmonary Disease (ABC) tool: study protocol of a cluster randomised trial in primary and secondary care.

Slok AH, In 't Veen JC, Chavannes NH, van der Molen T, Mölken MP, Kerstjens HA, Asijee GM, Salomé PL, Holverda S, Dekhuijzen RP, Schuiten D, van Breukelen G, Kotz D, van Schayck OC.

BMC Pulm Med. 2014 Aug 7;14:131. doi: 10.1186/1471-2466-14-131.

4.

An early rehabilitation intervention to enhance recovery during hospital admission for an exacerbation of chronic respiratory disease: randomised controlled trial.

Greening NJ, Williams JE, Hussain SF, Harvey-Dunstan TC, Bankart MJ, Chaplin EJ, Vincent EE, Chimera R, Morgan MD, Singh SJ, Steiner MC.

BMJ. 2014 Jul 8;349:g4315. doi: 10.1136/bmj.g4315.

5.

Influence of macrolide maintenance therapy and bacterial colonisation on exacerbation frequency and progression of COPD (COLUMBUS): study protocol for a randomised controlled trial.

Uzun S, Djamin RS, Kluytmans J, Van't Veer NE, Ermens AA, Pelle AJ, Mulder P, van der Eerden MM, Aerts J.

Trials. 2012 Jun 9;13:82. doi: 10.1186/1745-6215-13-82.

6.

A self-management approach using self-initiated action plans for symptoms with ongoing nurse support in patients with Chronic Obstructive Pulmonary Disease (COPD) and comorbidities: the COPE-III study protocol.

Lenferink A, Frith P, van der Valk P, Buckman J, Sladek R, Cafarella P, van der Palen J, Effing T.

Contemp Clin Trials. 2013 Sep;36(1):81-9. doi: 10.1016/j.cct.2013.06.003. Epub 2013 Jun 14.

PMID:
23770110
7.

Guideline for the management of chronic obstructive pulmonary disease--2011 update.

Abdool-Gaffar MS, Ambaram A, Ainslie GM, Bolliger CT, Feldman C, Geffen L, Irusen EM, Joubert J, Lalloo UG, Mabaso TT, Nyamande K, O'Brien J, Otto W, Raine R, Richards G, Smith C, Stickells D, Venter A, Visser S, Wong M; COPD Working Group.

S Afr Med J. 2011 Jan;101(1 Pt 2):63-73. Erratum in: S Afr Med J. 2011 May;101(5):288.

PMID:
21526617
8.

A 1-year prospective cost-effectiveness analysis of roflumilast for the treatment of patients with severe chronic obstructive pulmonary disease.

Rutten-van Mölken MP, van Nooten FE, Lindemann M, Caeser M, Calverley PM.

Pharmacoeconomics. 2007;25(8):695-711.

PMID:
17640111
9.

Incidence and risk factors of exacerbations among COPD patients in primary health care: APMPOC study.

Borrell E, Rodríguez M, Torán P, Muñoz L, Pera G, Montellà N, Monteagudo M, Urrea M, Puigfel Y, Negrete A, Mezquiriz X, Domènech C, Lacasta A, García ML, Maneus S, Tintoré G.

BMC Public Health. 2009 Jan 9;9:8. doi: 10.1186/1471-2458-9-8.

10.

Indacaterol therapy in moderate-to-severe chronic obstructive pulmonary disease: findings from a single-center primary care cohort.

Singh MP.

Int J Chron Obstruct Pulmon Dis. 2013;8:613-9. doi: 10.2147/COPD.S53707. Epub 2013 Dec 9.

11.

Do frequent moderate exacerbations contribute to progression of chronic obstructive pulmonary disease in patients who are ex-smokers?

Dreyse J, Díaz O, Repetto PB, Morales A, Saldías F, Lisboa C.

Int J Chron Obstruct Pulmon Dis. 2015 Mar 10;10:525-33. doi: 10.2147/COPD.S76475. eCollection 2015.

12.

Efficacy of a multifactorial intervention on therapeutic adherence in patients with chronic obstructive pulmonary disease (COPD): a randomized controlled trial.

Leiva-Fernández J, Leiva-Fernández F, García-Ruiz A, Prados-Torres D, Barnestein-Fonseca P.

BMC Pulm Med. 2014 Apr 25;14:70. doi: 10.1186/1471-2466-14-70.

13.

ICE COLD ERIC--International collaborative effort on chronic obstructive lung disease: exacerbation risk index cohorts--study protocol for an international COPD cohort study.

Siebeling L, ter Riet G, van der Wal WM, Geskus RB, Zoller M, Muggensturm P, Joleska I, Puhan MA.

BMC Pulm Med. 2009 May 6;9:15. doi: 10.1186/1471-2466-9-15.

14.

Evaluation of a combined strategy directed towards health-care professionals and patients with chronic obstructive pulmonary disease (COPD): information and health education feedback for improving clinical monitoring and quality-of-life.

Valero C, Monteagudo M, Llagostera M, Bayona X, Granollers S, Acedo M, Ferro JJ, Rodríguez-Latre L, Almeda J, Muñoz L; COPD Group of SAP Baix LLobregat Centre.

BMC Public Health. 2009 Dec 1;9:442. doi: 10.1186/1471-2458-9-442.

15.

Effect of 1-year treatment with roflumilast in severe chronic obstructive pulmonary disease.

Calverley PM, Sanchez-Toril F, McIvor A, Teichmann P, Bredenbroeker D, Fabbri LM.

Am J Respir Crit Care Med. 2007 Jul 15;176(2):154-61. Epub 2007 Apr 26.

PMID:
17463412
16.

Chronic obstructive pulmonary disease self-management activation research trial (COPD-SMART): design and methods.

Ashmore J, Russo R, Peoples J, Sloan J, Jackson BE, Bae S, Singh KP, Blair SN, Coultas D.

Contemp Clin Trials. 2013 Jul;35(2):77-86. doi: 10.1016/j.cct.2013.05.004. Epub 2013 May 13.

17.

Effects of respiratory therapist-directed protocol on prescription and outcomes of pulmonary rehabilitation in COPD inpatients.

Tramacere A, Rizzardi R, Cilione C, Serri B, Florini F, Lorenzi MC, Clini E.

Respiration. 2004 Jan-Feb;71(1):60-5.

PMID:
14872112
18.

Panax ginseng C.A Meyer root extract for moderate chronic obstructive pulmonary disease (COPD): study protocol for a randomised controlled trial.

Xue CC, Shergis JL, Zhang AL, Worsnop C, Fong H, Story D, Da Costa C, Thien FC.

Trials. 2011 Jun 30;12:164. doi: 10.1186/1745-6215-12-164.

19.

Effectiveness of integrated disease management for primary care chronic obstructive pulmonary disease patients: results of cluster randomised trial.

Kruis AL, Boland MR, Assendelft WJ, Gussekloo J, Tsiachristas A, Stijnen T, Blom C, Sont JK, Rutten-van Mölken MP, Chavannes NH.

BMJ. 2014 Sep 10;349:g5392. doi: 10.1136/bmj.g5392.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk